These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
212 related items for PubMed ID: 36070032
21. Implanting totally implantable venous access port via the internal jugular vein guided by ultrasonography is feasible and safe in patients with breast cancer. Zhou J, Qian S, He W, Han G, Li H, Luo R. World J Surg Oncol; 2014 Dec 08; 12():378. PubMed ID: 25487539 [Abstract] [Full Text] [Related]
22. Perioperative and Postoperative Complications of Supraclavicular, Ultrasound-Guided, Totally Implantable Venous Access Port via the Brachiocephalic Vein in Adult Patients: A Retrospective Multicentre Study. Yu Z, Sun X, Bai X, Ding W, Wang W, Xu L, Qin W, Wen L, Jin Y. Ther Clin Risk Manag; 2021 Dec 08; 17():137-144. PubMed ID: 33568912 [Abstract] [Full Text] [Related]
23. Short-term and long-term outcome of radiological-guided insertion of central venous access port devices implanted at the forearm: a retrospective monocenter analysis in 1704 patients. Wildgruber M, Borgmeyer S, Haller B, Jansen H, Gaa J, Kiechle M, Meier R, Ettl J, Berger H. Eur Radiol; 2015 Mar 08; 25(3):606-16. PubMed ID: 25239184 [Abstract] [Full Text] [Related]
24. [Complications after insertion of a totally implantable venous access port in patients treated with chemotherapy for head and neck squamous cell carcinoma]. Hoareau-Gruchet F, Rtail R, Sulaj H, Khirnetkina A, Reyt E, Righini CA. Ann Otolaryngol Chir Cervicofac; 2009 Apr 08; 126(2):43-52. PubMed ID: 19324328 [Abstract] [Full Text] [Related]
25. Totally implantable central venous access ports for long-term chemotherapy. A prospective study analyzing complications and costs of 333 devices with a minimum follow-up of 180 days. Biffi R, de Braud F, Orsi F, Pozzi S, Mauri S, Goldhirsch A, Nolè F, Andreoni B. Ann Oncol; 1998 Jul 08; 9(7):767-73. PubMed ID: 9739444 [Abstract] [Full Text] [Related]
26. Systemic thrombolysis and anticoagulation therapy for catheter-related right atrial thrombosis caused by TIVAP: A case report and review of the literature. Zhang Y, Shi J, Li JJ, Zhang L, Li Y. J Vasc Access; 2022 Mar 08; 23(2):313-317. PubMed ID: 33506722 [Abstract] [Full Text] [Related]
27. Silver-Mixed Port Reduces Venous Access Port Related Infection Rate Compared to Non-Silver-mixed Port: A Single-center Retrospective Analysis. Suzuki T, Michimoto K, Hasumi J, Kisaki S, Hasegawa Y, Fujimori A, Yoshimatsu L, Ashida H, Ojiri H. Cardiovasc Intervent Radiol; 2023 Dec 08; 46(12):1696-1702. PubMed ID: 37902854 [Abstract] [Full Text] [Related]
28. Surgical procedures and complications in placement of totally implantable venous access port in pediatric hemophilia patients: A retrospective analysis. Cheng W, Zhang J, Wang X, Liu G, Yao W, Wang C, Wu R, Li Z. Blood Cells Mol Dis; 2024 Sep 08; 108():102862. PubMed ID: 38889659 [Abstract] [Full Text] [Related]
29. Implantation of central venous ports with catheter insertion via the right internal jugular vein in oncology patients: single center experience. Charvát J, Linke Z, Horáèková M, Prausová J. Support Care Cancer; 2006 Nov 08; 14(11):1162-5. PubMed ID: 16596418 [Abstract] [Full Text] [Related]
30. The Safety Level of Total Central Venous Access Port Implantation Performed by Residents. Schreckenbach T, Münch I, El Youzouri H, Bechstein WO, Habbe N. J Surg Educ; 2019 Nov 08; 76(1):182-192. PubMed ID: 30120065 [Abstract] [Full Text] [Related]
31. Efficacy and safety of ultrasound-guided totally implantable venous access ports via the right innominate vein in adult patients with cancer: Single-centre experience and protocol. Sun X, Xu J, Xia R, Wang C, Yu Z, Zhang J, Bai X, Jin Y. Eur J Surg Oncol; 2019 Feb 08; 45(2):275-278. PubMed ID: 30087070 [Abstract] [Full Text] [Related]
32. Totally implantable venous access ports: retrospective review of long-term complications in 81 patients. Bassi KK, Giri AK, Pattanayak M, Abraham SW, Pandey KK. Indian J Cancer; 2012 Feb 08; 49(1):114-8. PubMed ID: 22842178 [Abstract] [Full Text] [Related]
33. Long-term, totally implantable central venous access ports connected to a Groshong catheter for chemotherapy of solid tumours: experience from 178 cases using a single type of device. Biffi R, Corrado F, de Braud F, de Lucia F, Scarpa D, Testori A, Orsi F, Bellomi M, Mauri S, Aapro M, Andreoni B. Eur J Cancer; 1997 Jul 08; 33(8):1190-4. PubMed ID: 9301441 [Abstract] [Full Text] [Related]
34. Safety of immediate use of totally implantable venous access ports in adult patients with cancer: a retrospective single-center study. Lee J, Hur SM, Kim Z, Lim CW. Korean J Clin Oncol; 2021 Dec 08; 17(2):104-110. PubMed ID: 36945672 [Abstract] [Full Text] [Related]
35. A novel incision technique of a totally implanted venous access port in the upper arm for patients with breast cancer. Song X, Chen S, Dai Y, Sun Y, Lin X, He J, Xu R. World J Surg Oncol; 2023 May 27; 21(1):162. PubMed ID: 37237419 [Abstract] [Full Text] [Related]
36. Evaluation of radiologically implanted central venous port systems explanted due to complications. Teichgräber UK, Kausche S, Nagel SN. J Vasc Access; 2011 May 27; 12(4):306-12. PubMed ID: 21534232 [Abstract] [Full Text] [Related]
37. Outcome of totally implantable venous-access port-related infections. Vidal M, Genillon JP, Forestier E, Trouiller S, Pereira B, Mrozek N, Aumeran C, Lesens O. Med Mal Infect; 2016 Feb 27; 46(1):32-8. PubMed ID: 26778362 [Abstract] [Full Text] [Related]
38. Totally implantable venous-access ports: local problems and extravasation injury. Kurul S, Saip P, Aydin T. Lancet Oncol; 2002 Nov 27; 3(11):684-92. PubMed ID: 12424071 [Abstract] [Full Text] [Related]
39. Clinical outcomes of totally implantable venous access port placement via the axillary vein in patients with head and neck malignancy. Hong S, Seo TS, Song MG, Seol HY, Suh SI, Ryoo IS. J Vasc Access; 2019 Mar 27; 20(2):134-139. PubMed ID: 29923460 [Abstract] [Full Text] [Related]